Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

Clinical trial NCT07715448 · COMPLETED

Trial details

NCT number: NCT07715448
Sponsor: Beni-Suef University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms Erectile Dysfunction

Primary completion: 2026-01-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.